Brighten: through surgery
In APP/PS1 (Amyloid Precursor Protein/Presenilin 1) transgenic mice, a well-characterized transgenic model of AD, HTyr treatment improves performance in the Morris water maze test, reduces cortical and hippocampal apoptosis, and restores synaptic integrity (42)
Sippel uses the KPro as a last resort intervention, when patients have corneal scarring and absolutely no tear function. Patients with the poorest prognosis for KPro are SJS patients, she said
Pediatric use of therapeutic peptides lacks sufficient safety and dosing data
Heres a visual breakdown of the pathways (including the Medical Device User Fee Amendments) for comparison: Ideally, youll be thinking about your regulatory strategy during design and development, as changes to the device may change its risk, and therefore your regulatory pathway